Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19 | Zendy

Louise Bowles | Zendy; Sean Platton | Zendy; Nada Yartey | Zendy; Minal Dave | Zendy; Kurtis Lee | Zendy; Daniel P. Hart | Zendy; Vickie MacDonald | Zendy; Laura Green | Zendy; Suthesh Sivapalaratnam | Zendy; John Pasi | Zendy; Peter MacCallum | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

Author(s) -

Louise Bowles,

Sean Platton,

Nada Yartey,

Minal Dave,

Kurtis Lee,

Daniel P. Hart,

Vickie MacDonald,

Laura Green,

Suthesh Sivapalaratnam,

John Pasi,

Peter MacCallum

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmc2013656

Subject(s) - lupus anticoagulant , partial thromboplastin time , medicine , covid-19 , prothrombin time , coagulation testing , thromboplastin , systemic lupus erythematosus , anticoagulant , coagulation , gastroenterology , pathology , thrombosis , disease , infectious disease (medical specialty) , outbreak

Prolonged aPTT in Patients with Covid-19 In this study, 20% of patients with Covid-19 had a prolonged activated partial-thromboplastin time (aPTT). In 90% of these cases, the cause was lupus antico...

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research